Early versus delayed evolocumab treatment and complex coronary artery revascularization.

求助中 10 由 guan 发布于 2026/7/5 13:10:01

DOI:10.1093/eurjpc/zwag304
作者：Paul M Haller, Prakriti Gaba, Colleen Thomas, Antonio Fagundes, Kazuma Oyama, Remo H M Furtado, Thomas A Zelniker, Julia Kuder, Sabina Murphy, Subodh Verma
文献类型：期刊论文
补充材料：只需要正文

Oxford University Press

Abstract：Background: In FOURIER, the PCSK9 inhibitor evolocumab (Evo) significantly reduced the rate of major adverse cardiovascular events and coronary revascularization.Aims: To investigate the eff

应助信息

等您来应助

上传文件

5小时前

Book学术机器人

2026/7/5 13:10:01 未找到该文献，机器人已退出，请等待人工下载

2026/7/5 13:10:01 Book学术AI机器人收到请求，开始寻找文献

2026/7/5 13:10:01 已向机器人发送请求

5小时前

guan 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:Royal Society of Chemistry (RSC)Developing diluted low-concentration electrolyte with a high anion-to-solvent ratio for high-voltage lithium metal batteries?